Bluepharma has strengthened its innovation capabilities with a new industrial facility dedicated to the development and manufacture of complex injectable medicines. Designed to meet the requirements of advanced therapeutic modalities, the facility integrates specialised technologies and expertise covering the entire lifecycle of complex formulations, from initial research and development through to GMP-compliant manufacturing.

RACE was responsible for the installation of the HVAC and BMS systems, delivering solutions tailored to the demanding requirements of pharmaceutical facilities.

The project included the production and distribution of hot and chilled water to supply the HVAC systems, including Air Handling Units (AHUs) and fan coil units, as well as other systems within the facility. These solutions ensure precise climate control and the strict environmental conditions required for pharmaceutical manufacturing.

The air treatment and distribution system comprises five AHUs, extraction systems, and supply, return and extraction ductwork networks. In the production areas and classified rooms, high-efficiency filtration solutions were implemented, including H14 HEPA filters, combined with temperature, humidity, airflow and differential pressure control. These systems ensure the environmental conditions required for safe and controlled pharmaceutical production.

The facility also features a BMS system for the supervision and monitoring of equipment and key installation parameters. This enables centralised, efficient control of the operating conditions of the HVAC systems and other technical systems throughout the facility.

Through this project, RACE contributed to the implementation of the technical infrastructure for Bluepharma’s new complex injectable manufacturing facility, integrating climate control, air treatment and distribution, and technical management solutions designed to meet the high standards of quality, safety and environmental control required in pharmaceutical manufacturing.